US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Cell-Free DNA (cfDNA) Testing Global Market - Forecast to 2022
6/10/2016 | published by: IQ4I Research and Consultancy
... personalized medicine, and improve the quality of life. The groundbreaking discovery of cfDNA in 1948 has opened up to new possibilities in the field of gynecology, oncology, transplantation and infectious diseases. The cell-free DNA testing ...  |  read more...
USD 4,500
Global Contraceptive Devices Industry 2016 Market Research Report
5/30/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Contraceptive Devices basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Global Breast Pump Market 2016-2020
6/1/2016 | published by: TechNavio - Infiniti Research Ltd.
... feeding their infants as and when required. For instance, when the mothers are not able to feed directly or are away for work, the stored milk can be fed to the infant by the caretakers. ...  |  read more...
USD 2,500
Global Prenatal Vitamin Supplements Market 2016-2020
6/1/2016 | published by: TechNavio - Infiniti Research Ltd.
... combination of substances such as minerals, amino acids, vitamins, and herbs. It may be available in various forms such as powders, pills, tablets, liquids, and gel capsules. Dietary supplements are taken basically for their nutritional ...  |  read more...
USD 2,500
Birth Control Products - Market Trends & Insights
6/1/2016 | published by: Global Industry Analysts
... market size for the year 2015. Also included are global competitive player market shares encompassing China, and the US. Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is ...  |  read more...
USD 1,495
Fertility and Pregnancy Rapid Test Kits Market: Global Industry Analysis and Opportunity Assessment 2016 - 2026
5/30/2016 | published by: Future Market Insights
... 2016 and 2026. In terms of value, the market is expected to register a CAGR of 4.1% over the forecast period. This study demonstrates global market dynamics and trends that are expected to influence the ...  |  read more...
USD 5,000
Global Breast Cancer Partnering 2010 to 2016
6/1/2016 | published by: Current Partnering
... Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by ...  |  read more...
USD 1,495
Global Infertility Partnering 2010 to 2016
6/1/2016 | published by: Current Partnering
... in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the ...  |  read more...
USD 1,495
Endometrial Cancer - Pipeline Review, H1 2016
5/18/2016 | published by: Global Markets Direct
... therapeutics under development for Endometrial Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2016
5/18/2016 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutics under development for Vaginal Atrophy (Atrophic Vaginitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...  |  read more...
USD 2,000
Global Cervical Cancer Partnering 2010 to 2016
6/1/2016 | published by: Current Partnering
... Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by ...  |  read more...
USD 1,495
Global Ovarian Cancer Partnering 2010 to 2016
6/1/2016 | published by: Current Partnering
... Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by ...  |  read more...
USD 1,495
Global Menopause Partnering 2010-2016
6/1/2016 | published by: Current Partnering
... deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading ...  |  read more...
USD 1,495
Global Human Papilloma Virus Partnering 2010 to 2016
6/1/2016 | published by: Current Partnering
... companies. Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into ...  |  read more...
USD 1,495
Global Sexual Dysfunction Partnering 2010 to 2016
6/1/2016 | published by: Current Partnering
... Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by ...  |  read more...
USD 1,495
US Female Infertility Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Female Infertility epidemiology, Female Infertility market valuations and forecast, Female Infertility products sales and competitive landscape in the US. classified into nine sections – Female Infertility overview including etiology, pathophysiology, and diagnosis, Female Infertility treatment ...  |  read more...
USD 990
Breast Lesion Localization Methods Market Comparative Analysis and End User Preference Study - (Market Assessment (Field Force, Comparative Analysis, Business Model, End User Preference Survey (Selection Criteria, Qualitative Analysis of Replacement Trend
4/15/2016 | published by: MarketsandMarkets
... Portfolio and Strategic Consolidation) Growing Number of Breast Cancer Surgeries and Implementation of Favorable Reimbursement Guidelines for Localization Devices are the Major Factors Driving the Breast Lesion Localization Methods Market The breast lesion localization methods ...  |  read more...
USD 5,650
Condom Market in the US 2016-2020
4/20/2016 | published by: TechNavio - Infiniti Research Ltd.
... As a method of birth control, male condoms have the advantage of being inexpensive and easy to use. Male condoms are primarily made from latex, but other materials such as polyurethane, polyisoprene, and lamb intestine ...  |  read more...
USD 2,500
Vulvovaginal Candidiasis - Pipeline Review, H1 2016
3/30/2016 | published by: Global Markets Direct
... therapeutics under development for Vulvovaginal Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Global Ovarian Cancer Treatment Drugs Industry 2016 Market Research Report
4/28/2016 | published by: 9Dimen Research
... (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Ovarian Cancer Treatment Drugs basics: definitions, classifications, applications and industry chain overview; industry policies and ...  |  read more...
USD 2,850
Metastatic Ovarian Cancer - Pipeline Review, H1 2016
4/20/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Metastatic Ovarian Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Women's Health Hospitals in the US - Industry Market Research Report
5/5/2016 | published by: IBISWorld
... young women against the human papillomavirus, along with an increased focus on preventive care, supported revenue growth. The industry is forecast to grow strongly in the next five-year period alongside the recovering economy. This industry ...  |  read more...
USD 1,020
Germany Breast Cancer Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Breast Cancer epidemiology, Breast Cancer market valuations and forecast, Breast Cancer products sales and competitive landscape in Germany. classified into nine sections – Breast Cancer overview including etiology, pathophysiology, and diagnosis, Breast Cancer treatment options, ...  |  read more...
USD 990
Post Menopausal Osteoporosis - Pipeline Review, H1 2016
4/27/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Global Postmenopausal Osteoporosis Drugs Market 2016-2020
5/11/2016 | published by: TechNavio - Infiniti Research Ltd.
... in osteoporosis, which is characterized by low bone density and structural deterioration of bone tissues, leading to fragile bones. Rapid bone resorption or slow bone replacement can result in the development of the disease. Gender, ...  |  read more...
USD 2,500
< prev 1    3  4  5  6  7  8  9  10